Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement

Hippocration General Hospital50 enrolled

Overview

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Prevention of Anemia

Interventions

IronDRUG

oral treatment

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age more or equal of 18 years 2. Registration consent 3. Have complete 12h week of pregnancy 4. Hemoglobin levels \<10,5 ptl 5. Hematocrit \< 32 % Exclusion Criteria: 1. Age \<18 years 2. Absent registration consent 3. Step of pregnancy less than 12 weeks 4. Coadministration formulations iron oral or parenterally 5. Background of liver kirrosis 6. Background of aimosidirosis 7. Background acquired or chronic aimatochromatosis 8. Aplastic , Hemolytic anemia and chronic diseases 9. Chronic pancreatitis 10. Subjective renal or/and liver disease 11. Hypothyroidism or yperthyreoeidismos

Outcomes

Primary Outcomes

Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter with questionnaire

Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant

Time frame: up to 24 months

Secondary Outcomes

adverse reactions

Time frame: up to 24 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.